{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:05:25Z","timestamp":1756339525667,"version":"3.44.0"},"reference-count":21,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2025,2,25]]},"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:p>Haemophagocytic lymphohistiocytosis (HLH) is a rare, life-threatening disorder of uncontrolled immune activation by macrophages, cytotoxic T cells and natural killer (NK) cells, marked by severe inflammation. It is often categorised as primary (genetic) or secondary (acquired). Here, a case of a young male with a history of stage IA seminoma in remission, who presented with persistent fevers, night sweats, weight loss and fatigue, is reported. He met \u22655 of 8 HLH-2004 criteria. Initial workup for secondary HLH, including infectious, autoimmune and malignancy, was negative. Bone marrow, sacral bone and splenic biopsies showed lymphohistiocytic infiltrates without malignancy. Genetic testing was unrevealing. With no identified aetiology and declining clinical status, the HLH-94 protocol was initiated. He improved initially, but fevers recurred, suggestive of HLH progression. A repeat positron emission tomography-CT (PET-CT) showed new hepatic hypermetabolic activity, leading to a biopsy diagnosing T-cell\/histiocyte-rich large B-cell lymphoma. This case highlights the challenges in identifying the aetiologies of secondary HLH, particularly searching for an occult malignancy and ensuring prompt treatment is initiated.<\/jats:p>","DOI":"10.1136\/bcr-2024-261845","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T08:05:32Z","timestamp":1741853132000},"page":"e261845","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Challenging diagnosis of haemophagocytic lymphohistiocytosis secondary to T-cell\/histiocyte-rich large B-cell lymphoma"],"prefix":"10.1136","volume":"18","author":[{"given":"Arnaud","family":"Wautlet","sequence":"first","affiliation":[{"name":"Allergy Immunology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amer","family":"Khojah","sequence":"additional","affiliation":[{"name":"Pediatrics, College of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristy","family":"Wolniak","sequence":"additional","affiliation":[{"name":"Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gayatri","family":"Patel","sequence":"additional","affiliation":[{"name":"Allergy Immunology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"key":"2025082708425770000_18.3.e261845.1","doi-asserted-by":"crossref","unstructured":"Al-Samkari H , Berliner N . Hemophagocytic lymphohistiocytosis. Annual review of pathology: mechanisms of disease. 2018;13:27\u201349.","DOI":"10.1146\/annurev-pathol-020117-043625"},{"key":"2025082708425770000_18.3.e261845.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61048-X"},{"key":"2025082708425770000_18.3.e261845.3","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102143","article-title":"Epidemiology, characteristics, and outcomes of adult haemophagocytic lymphohistiocytosis in the USA, 2006-19: a national, retrospective cohort study","volume":"62","author":"Abdelhay","year":"2023","journal-title":"EClinicalMedicine"},{"key":"2025082708425770000_18.3.e261845.4","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2018894618"},{"key":"2025082708425770000_18.3.e261845.5","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1182\/blood.2019000936","article-title":"Pediatric hemophagocytic lymphohistiocytosis","volume":"135","author":"Canna","year":"2020","journal-title":"Blood"},{"key":"2025082708425770000_18.3.e261845.6","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1007\/s00277-020-04083-6","article-title":"A comprehensive analysis of adult patients with secondary hemophagocytic lymphohistiocytosis: a prospective cohort study","volume":"99","author":"Yoon","year":"2020","journal-title":"Ann Hematol"},{"key":"2025082708425770000_18.3.e261845.7","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1080\/10428194.2020.1737684","article-title":"Clinical outcomes of adults with hemophagocytic lymphohistiocytosis treated with the HLH-04 protocol: a retrospective analysis","volume":"61","author":"Bubik","year":"2020","journal-title":"Leuk Lymphoma"},{"key":"2025082708425770000_18.3.e261845.8","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2015.123562"},{"key":"2025082708425770000_18.3.e261845.9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-01-551622"},{"key":"2025082708425770000_18.3.e261845.10","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/art.38690","article-title":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome","volume":"66","author":"Fardet","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2025082708425770000_18.3.e261845.11","doi-asserted-by":"crossref","first-page":"e630","DOI":"10.1016\/S2352-3026(19)30156-5","article-title":"Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial","volume":"6","author":"Ahmed","year":"2019","journal-title":"Lancet Haematol"},{"key":"2025082708425770000_18.3.e261845.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2013.09.007"},{"key":"2025082708425770000_18.3.e261845.13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-04-1030"},{"key":"2025082708425770000_18.3.e261845.14","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.11233"},{"key":"2025082708425770000_18.3.e261845.15","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.clicom.2023.02.008","article-title":"X-Linked Inhibitor of Apoptosis (XIAP) deficiency presenting as hemophagocytic lymphohistiocytosis triggered by drug allergy","volume":"3","author":"Khojah","year":"2023","journal-title":"Clin Immunol Commun"},{"key":"2025082708425770000_18.3.e261845.16","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-03-278127"},{"key":"2025082708425770000_18.3.e261845.17","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2016.125","article-title":"Splenectomy as a diagnostic method in lymphoma-associated hemophagocytic lymphohistiocytosis of unknown origin","volume":"7","author":"Ma","year":"2017","journal-title":"Blood Cancer J"},{"key":"2025082708425770000_18.3.e261845.18","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1016\/S2352-3026(21)00366-5","article-title":"Malignancy-associated haemophagocytic lymphohistiocytosis","volume":"9","author":"Setiadi","year":"2022","journal-title":"Lancet Haematol"},{"key":"2025082708425770000_18.3.e261845.19","article-title":"T Cell Histiocyte Rich Large B Cell Lymphoma Presenting as Hemophagocytic Lymphohistiocytosis: An Uncommon Presentation of a Rare Disease","volume":"2017","author":"Ibrahim","year":"2017","journal-title":"Case Rep Oncol Med"},{"key":"2025082708425770000_18.3.e261845.20","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41375-024-02135-8","article-title":"Lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH): a scoping review unveils clinical and diagnostic patterns of a lymphoma subgroup with poor prognosis","volume":"38","author":"Knauft","year":"2024","journal-title":"Leukemia"},{"key":"2025082708425770000_18.3.e261845.21","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.073098"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2024-261845","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T15:43:05Z","timestamp":1756309385000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2024-261845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":21,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3,13]]},"published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10.1136\/bcr-2024-261845"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2024-261845","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2025,3]]}}}